Literature DB >> 21710143

The P2Y(12) receptor as a target of antithrombotic drugs.

Stephen O'Connor1, Gilles Montalescot, Jean-Philippe Collet.   

Abstract

Year:  2011        PMID: 21710143      PMCID: PMC3166993          DOI: 10.1007/s11302-011-9241-z

Source DB:  PubMed          Journal:  Purinergic Signal        ISSN: 1573-9538            Impact factor:   3.765


× No keyword cloud information.
  57 in total

1.  ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine.

Authors:  Jeffrey L Anderson; Cynthia D Adams; Elliott M Antman; Charles R Bridges; Robert M Califf; Donald E Casey; William E Chavey; Francis M Fesmire; Judith S Hochman; Thomas N Levin; A Michael Lincoff; Eric D Peterson; Pierre Theroux; Nanette Kass Wenger; R Scott Wright; Sidney C Smith; Alice K Jacobs; Jonathan L Halperin; Sharon A Hunt; Harlan M Krumholz; Frederick G Kushner; Bruce W Lytle; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
Journal:  Circulation       Date:  2007-08-06       Impact factor: 29.690

Review 2.  Regulation of platelet functions by P2 receptors.

Authors:  Christian Gachet
Journal:  Annu Rev Pharmacol Toxicol       Date:  2006       Impact factor: 13.820

3.  The effect of CYP2C19 polymorphism on the pharmacokinetics and pharmacodynamics of clopidogrel: a possible mechanism for clopidogrel resistance.

Authors:  K A Kim; P W Park; S J Hong; J-Y Park
Journal:  Clin Pharmacol Ther       Date:  2008-03-05       Impact factor: 6.875

4.  Optimal use of thienopyridines in non-ST-elevation acute coronary syndrome following CURRENT-OASIS 7.

Authors:  Johanne Silvain; Anne Bellemain-Appaix; Olivier Barthélémy; Farzin Beygui; Jean-Philippe Collet; Gilles Montalescot
Journal:  Circ Cardiovasc Interv       Date:  2011-02-01       Impact factor: 6.546

5.  A selective role for phosphatidylinositol 3,4,5-trisphosphate in the Gi-dependent activation of platelet Rap1B.

Authors:  Paolo Lova; Simona Paganini; Emilio Hirsch; Laura Barberis; Matthias Wymann; Fabiola Sinigaglia; Cesare Balduini; Mauro Torti
Journal:  J Biol Chem       Date:  2002-10-28       Impact factor: 5.157

Review 6.  Pharmacokinetic and metabolic characteristics of ticlopidine in relation to its inhibitory properties on platelet function.

Authors:  C Picard-Fraire
Journal:  Agents Actions Suppl       Date:  1984

Review 7.  The platelet P2Y₁₂ receptor for adenosine diphosphate: congenital and drug-induced defects.

Authors:  Marco Cattaneo
Journal:  Blood       Date:  2010-10-21       Impact factor: 22.113

8.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.

Authors: 
Journal:  Lancet       Date:  1996-11-16       Impact factor: 79.321

9.  Clopidogrel non-responsiveness and risk of cardiovascular morbidity. An updated meta-analysis.

Authors:  Francesco Sofi; Rossella Marcucci; Anna Maria Gori; Betti Giusti; Rosanna Abbate; Gian Franco Gensini
Journal:  Thromb Haemost       Date:  2010-02-02       Impact factor: 5.249

10.  Intravenous platelet blockade with cangrelor during PCI.

Authors:  Deepak L Bhatt; A Michael Lincoff; C Michael Gibson; Gregg W Stone; Steven McNulty; Gilles Montalescot; Neal S Kleiman; Shaun G Goodman; Harvey D White; Kenneth W Mahaffey; Charles V Pollack; Steven V Manoukian; Petr Widimsky; Derek P Chew; Fernando Cura; Ivan Manukov; Frantisek Tousek; M Zubair Jafar; Jaspal Arneja; Simona Skerjanec; Robert A Harrington
Journal:  N Engl J Med       Date:  2009-12-10       Impact factor: 91.245

View more
  4 in total

Review 1.  P2Y(12) receptors in platelets and other hematopoietic and non-hematopoietic cells.

Authors:  Christian Gachet
Journal:  Purinergic Signal       Date:  2012-04-11       Impact factor: 3.765

2.  P2Y12 inhibitor clopidogrel inhibits renal fibrosis by blocking macrophage-to-myofibroblast transition.

Authors:  Junzhe Chen; Ying Tang; Yu Zhong; Biao Wei; Xiao-Ru Huang; Patrick Ming-Kuen Tang; Anping Xu; Hui-Yao Lan
Journal:  Mol Ther       Date:  2022-07-05       Impact factor: 12.910

Review 3.  Blood cells: an historical account of the roles of purinergic signalling.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2015-08-11       Impact factor: 3.765

4.  Inhibiting P2Y12 in Macrophages Induces Endoplasmic Reticulum Stress and Promotes an Anti-Tumoral Phenotype.

Authors:  Nataša Pavlović; Maria Kopsida; Pär Gerwins; Femke Heindryckx
Journal:  Int J Mol Sci       Date:  2020-10-31       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.